MarketPulse
C

$CRL

6 articles found
5 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Plasmid DNA Market Set to Quadruple to $10.8B by 2034 on Gene Therapy Boom

Plasmid DNA manufacturing market projected to reach $10.8B by 2034 from $2.4B in 2025 on strong gene therapy demand growth.
TMODHRCRLLZAGYWUXAYgene therapyCAR T-cell therapy
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Gene Therapy's Hidden Engine: AAV Vector Market Poised to Explode 22% Annually Through 2034

AAV vector manufacturing market to surge from $874M (2025) to $5.2B (2034) as gene therapy breakthroughs drive demand for specialized production infrastructure.
TMOCRLLZAGYgene therapybiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Drug Development Services Market Set to Double to $50B by 2030

Drug development services market projected to reach $50.26B by 2030 from $28.09B in 2025, driven by AI adoption, personalized medicine, and emerging market expansion.
CRLIQVLZAGYLHWUXAYregulatory complianceclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Veterinary Clinical Trial Standards Tighten: New GCP Training Addresses Global Regulatory Compliance

ResearchAndMarkets launches May 2026 VICH GCP training for veterinary clinical trials, addressing regulatory harmonization and compliance requirements across EU and USA markets.
CRLregulatory compliancedata quality
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

Pharma QC Testing Market to Reach $17.65B by 2035 on AI, Automation Surge

Global pharmaceutical microbiology QC testing market projected to grow from $5.08B in 2025 to $17.65B by 2035, driven by automation and AI adoption.
TMODHRCRLMKKGYBDX+2regulatory compliancemarket forecast
BenzingaBenzinga··Vandana Singh

Charles River Labs to Divest CDMO and Discovery Units in Strategic Restructuring

Charles River Labs divests CDMO and discovery units to GI Partners and IQVIA, reducing revenue but boosting profitability and raising 2026 earnings guidance.
CRLIQVearnings guidancedivestiture